![](/img/cover-not-exists.png)
Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Patrizio Mattei, Markus Boehringer, Patrick Di Giorgio, Holger Fischer, Michael Hennig, Joerg Huwyler, Buelent Koçer, Bernd Kuhn, Bernd M. Loeffler, Alexander MacDonald, Robert Narquizian, Etienne RauVolume:
20
Year:
2010
Language:
english
Pages:
5
DOI:
10.1016/j.bmcl.2009.12.024
File:
PDF, 413 KB
english, 2010